Value of hsCRP and Alb in Evaluating the Prognosis of Patients with Systemic Lupus Erythematosus
2017
OBJECTIVE: To study the value of hsCRP and Alb in evaluating the prognosis of patients with systemic lupus erythematosus (SLE). METHODS: 126 SLE patients from January 2011 to January 2016 were enrolled in this study, and their clinical data were collected, including SLEDAI, hsCRP and Alb and complications. The correlation between hsCRP/Alb ratio and SLEDAI after treatment was analyzed. All patients were followed up after discharge, and the prognosis-related factors were analyzed. RESULTS: After treatment, hsCRP/Alb ratio of patients with SLEDAI 10-14 score was significantly higher than that of 5-9 and 0-4 score(P 0.05). after treatment SLEDAI ≥10 score, hsCRP/Alb≥0.05 mg/g and complications significantly correlated with prognosis of patients(P<0.05). CONCLUSION: hsCRP/Alb correlates with the prognosis of patients with SLE at a certam level.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI